$LTH

Life Time (LTH) Q2 2026 Earnings Call Transcript

Life Time Group Holdings (LTH) reported Q2 2026 results on an earnings call. Total revenue rose 13.7% to $866.0 million, with comparable center revenue up 9.1%. Adjusted EBITDA increased 16.8% to $246.5 million. Full-year guidance was raised to $3.35-$3.375 billion revenue and $940-$955 million adjusted EBITDA. The company plans 14 new clubs in 2026 and 12-14 in 2027.

Original reporting
Published Aug 8, 2026, 2:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 2:39 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Life Time (LTH) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$LTHBullishMed
01

Why it matters

Traders can update FY 2026 expectations using the raised revenue range and adjusted EBITDA guidance midpoint, while monitoring membership mix shifts and MIORA technology/process execution risk.

02

Market read

A guidance raise with margin expansion is the primary catalyst, but the medical membership decline and MIORA tech/process challenges add downside risk to the narrative.

03

What to watch

Large capex and sale-leaseback reliance ($400M target) increase sensitivity to financing/real-estate market conditions, and MIORA clinic expansion is contingent on perfecting the customer experience model.

Relevance 8/10Novelty 8/10Timing: post-earnings call, guidance update for FY 2026

Background

The article is a transcript-style summary of Life Time Group Holdings’ Q2 2026 earnings call, including financial results, guidance, capital allocation, and initiative updates (CTR, Hybrid XT, MIORA).

Company-level read

Ticker impact

$LTHBullishMedium confidence
Context

Life Time reported Q2 revenue of $866.0M, raised full-year revenue guidance to $3.35B-$3.375B, and increased adjusted EBITDA margin midpoint to 28.2%.

Expected impact

Likely positive near-term bias as traders reprice FY revenue and EBITDA margin, tempered by membership-mix and MIORA execution risk.

Evidence & confidence

The article contains multiple fresh, decision-relevant datapoints: raised revenue range, raised EBITDA guidance midpoint, higher capex tied to new centers, and a specific risk quote about technology/process challenges for MIORA.

Market effects

Signals continued demand for premium fitness formats and spa/personal training mix, while highlighting execution risk in wellness/clinic initiatives.

Urban expansion pipeline (e.g., New York and Miami) may support local commercial real estate and staffing demand tied to new club openings.

Limited direct global linkage; primarily a US fitness operator read-through on consumer discretionary and health/wellness spending.

Counterpoint

The sharp decline in qualified medical memberships (down 18.9% in Q2) could pressure longer-term revenue durability if standard memberships do not fully offset insured-plan churn.

Key entities

  • Life Time Group Holdings Inc.

    Reported Q2 results and raised FY 2026 revenue and adjusted EBITDA guidance; discussed membership mix strategy, capex, sale-leasebacks, and MIORA initiative risks.

  • Bahram Akradi

    CEO who discussed balance sheet optionality, MIORA incubation, and expansion plans.

  • Erik Weaver

    CFO who presented Q2 financial performance and guidance details.

Related articles

$LTHHighAI 9/10

Life Time Reports Second Quarter 2026 Financial Results

Life Time Group Holdings (NYSE: LTH) reported Q2 2026 revenue of $866.0 million, up 13.7% year over year. Net income rose to $101.4 million (+40.6%), and diluted EPS was $0.45 (+40.6%). Adjusted EBITDA increased to $246.5 million (+16.8%). The company reiterated and updated its 2026 outlook, including opening 14 new clubs.

$LTHHigh

Life Time Group Holdings, Inc. (LTH): Results of Operations and Financial Condition

Life Time Group Holdings, Inc. (LTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 lth-20260630xex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Life Time Reports Second Quarter 2026 Financial Results • Total revenue of $866.0 million increased 13.7% over the prior year quarter • Net income of $101.4 million increased 40.6% over the prior

$XOMMed

Guyana’s oil helps cushion impacts from Middle East disruption - Exxon

ExxonMobil said its Q2 2026 production was below Q2 2025, but profits rose to about $14.5B, citing Middle East disruptions being mostly offset by Permian and Guyana growth. It reported 4.51M bpd total output, including ~870,000 bpd from Guyana’s Stabroek. Exxon expects Guyana output to rise with the Errea Wittu FPSO and further projects like Whiptail and Hammerhead, per its SEC filing.

$DLXMed

Deluxe Q2 Earnings Call Highlights

Deluxe (NYSE:DLX) reported Q2 segment results, led by Data Solutions revenue up 21.4% to $82.3M and adjusted EBITDA of $18.1M. Merchant Services revenue rose 6.1% to $107.6M. Print revenue fell 4.3% to $235.9M. Deluxe closed its Celero acquisition on July 31 and raised 2026 guidance: revenue $2.095B-$2.12B, adj. EBITDA $455M-$475M, adj. EPS $3.60-$4.00, and FCF about $200M.

$NEOGMedAI 8/10

Neogen (NEOG) Q4 2026 Earnings Call Transcript

Neogen (NEOG) reported fiscal Q4 2026 revenue of $225.3 million, up 4.3% in core growth, led by Food Safety. Adjusted gross margin rose to 49.7% and adjusted EBITDA grew 12% to $45.4 million. FY2027 guidance: revenue $880-$885 million and adjusted EBITDA $180-$182 million. The company plans a 50% R&D increase and a $140 million genomics divestiture for debt reduction.